Phoenix Life Sciences International Announces Doctor Mohyuddin Mirza as Company's New Botany Specialist
December 19 2018 - 9:00AM
InvestorsHub Cannabis NewsWire
Phoenix Life
Sciences International Announces Doctor Mohyuddin Mirza as
Company’s New Botany
Specialist
Denver, CO --
December 19, 2018 -- InvestorsHub NewsWire -- Phoenix Life Sciences
International Limited (OTC: PLSI) (“Phoenix Life”), an
international adaptive healthcare solutions company, today
announced that Mohyuddin Mirza has joined the company as the Botany
Specialist.
Dr. Mohyuddin
Mirza has over three decades of experience
in the management of greenhouse crops from
farm to consumers including Echinacea, Rhodeola and Cannabis and
has made a significant
economical impact on the botanical products industries in Alberta,
Canada. He pioneered the
industry by introducing hydroponics and soilless crop production to
indoor growing and played a pivotal role in growing the greenhouse
industry from a $25 million to $160 million business from 1980 to
2014. He is the receipient of Alberta Agriculture Hall of Fame in
2014
“As Phoenix Life
Sciences International moves forward with company expansion in the
new year, we are proud to recruit the most well-respected
specialists in the growing industry, like Mohyuddin Mirza,” said
Phoenix Life Sciences International CEO Martin Tindall. “Dr.
Mirza’s growing expertise will be pivotal in building out the crop
capacity to push forward our mission of transforming the future of
global healthcare.”
Dr. Mirza has
received numerous awards within the Alberta greenhouse industry and
helped create the Alberta Greenhouse Growers Association. He is the
author of hundred of educational articles published in magazines
like Greenhouse Canada and more recently Grow
Opportunity.
“Considering the
immense benefits of botanical pharmaceuticals in serving as an
effective alternative for treating a wide range of conditions, I am
proud to join Phoenix Life as it expands internationally,” said Dr.
Mohyuddin Mirza. “I am looking forward to putting my decades of
indoor growing expertise toward helping the company expand to help
patients in need globally.”
To learn more
about Phoenix Life Sciences International, please visit https://plsi.co/#about.
###
About Phoenix
Life Sciences International
Limited
Phoenix Life
Sciences International Limited is an adaptive healthcare solutions
company. Our business is to advance research and integrate programs
and manufacturing of products that target and treat diabetes, pain,
cancer, and address psychological, gastrointestinal, autoimmune,
neurological and sleep disorders. We strive to create partnerships
and integrate these programs for human health into communities
worldwide as part of our Global Health
Initiative.
FORWARD-LOOKING
STATEMENTS
Information
contained in this press release regarding Phoenix Life Sciences
International, Limited and its subsidiaries, (the “Companies”) may
constitute forward-looking statements or statements which may be
deemed or construed to be forward-looking statements. The words
“plan”, “forecast”, “anticipates”, “estimate”, “project”, “intend”,
“expect”, “should”, “believe,” and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to, known and unknown risks,
uncertainties and other factors which could cause the Company’s
actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and other
factors are more fully discussed in the Company’s filings with the
U.S. Securities and Exchange Commission. All forward-looking
statements attributable to the Companies herein are expressly
qualified in their entirety by the above-mentioned cautionary
statement. The Companies disclaim any obligation to update
forward-looking statements contained in this press release, except
as may be required by
law.
FOOD AND DRUG
ADMINISTRATION (FDA)
DISCLOSURE
These statements
have not been evaluated by the FDA and therefore the products sold
by Phoenix Life Sciences International are not available on
U.S.
LEGAL
DISCLOSURE
Phoenix Life
Sciences International does not sell or distribute any products in
the United States that are in violation of the United States
Controlled Substances Act (US.CSA). This company does not grow,
sell, and distribute cannabis-based products in the United States
and is solely involved with the legal distribution of medical
cannabis-based products within certain international markets
outside of the United
States.
Investor
Contact:
Phone:
1.888.717.5655 or international
+1.720.699.7222
E-mail: investor.relations@phoenixlife.co
Media
Contact:
Kathryn
Reinhardt
CMW
Media
Kathryn@cmwmedia.com
619-972-3089